Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlorambucil-associated pneumonitis

B Crestani1, A Jaccard, D Israël-Biet

  • 1Immuno-Hematology Unit, Hôpital Saint Louis, Paris, France.

Chest
|February 1, 1994
PubMed
Summary

A patient experienced interstitial pneumonitis during chlorambucil treatment for chronic lymphocytic leukemia. Lung inflammation resolved after stopping the drug, suggesting a drug-induced hypersensitivity pneumonitis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Beyond pulmonary function: toward personalized work ability assessment in sarcoidosis].

Revue des maladies respiratoires·2026
Same author

[Accuracy of two connected devices for SpO<sub>2</sub> sampling: Observational study].

Revue des maladies respiratoires·2026
Same author

Hypoglossal nerve stimulation in the treatment of obstructive sleep apnea: Update on French practices and position paper of the SFRMS, SPLF and SFORL sleep medicine work-group.

European annals of otorhinolaryngology, head and neck diseases·2025
Same author

[Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)].

Revue des maladies respiratoires·2025
Same author

[Low-dose methotrexate: Indications and side effects, particularly in cases of diffuse interstitial pneumonia].

Revue des maladies respiratoires·2024
Same author

Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023

Area of Science:

  • Pulmonology
  • Oncology
  • Immunology

Background:

  • Chronic lymphocytic leukemia (CLL) is a common hematologic malignancy.
  • Chlorambucil is an alkylating agent used in CLL treatment.
  • Interstitial pneumonitis is a potential adverse effect of chemotherapy.

Observation:

  • A patient on chlorambucil for CLL developed interstitial pneumonitis.
  • Bronchoalveolar lavage revealed T-lymphocytic alveolitis.
  • Blood lymphocytes were predominantly B-cell phenotype, contrasting with lung findings.

Findings:

  • Discontinuation of chlorambucil led to rapid clinical improvement.
  • Persistent T-lymphocytic alveolitis with a CD8+ phenotype was observed post-treatment.
  • The lung immune profile resembled drug-induced hypersensitivity pneumonitis.

Related Experiment Videos

Implications:

  • This case highlights chlorambucil-induced hypersensitivity pneumonitis.
  • T-lymphocytic alveolitis may be a marker for drug-induced lung injury.
  • Careful monitoring for pulmonary complications is crucial in patients receiving chlorambucil.